The Wistar Institute
After 10 Years as Chief Financial Officer, Joe Trainor Readies for Retirement
It is often said that the measure of a person is in more than just their accomplishments. For Dario Altieri, CEO of The Wistar Institute, trying to sum up the tenure of Joe Trainor, who will be retiring this month as Wistar’s Chief Financial Offic…
GeneOne and Wistar Institute Collaborate to Develop Small Molecule Therapeutics to Protect Humans from Nipah Virus
PHILADELPHIA — (May 10, 2023) — GeneOne Life Science, Inc.(“GeneOne” KOSPI: 011000), a leading biopharmaceutical company specializing in developing nucleic-acid based treatments and novel small-molecule therapeutics, and The Wistar Institute, an i…
The Wistar Institute, Pennsylvania Biotechnology Center and Baruch S. Blumberg Institute Forge Strategic Collaboration to Support Regional Biotech Startups
PHILADELPHIA — (MAY 9, 2023) — The Wistar Institute has formed a new strategic collaboration with the Pennsylvania Biotechnology Center (PABC) and the Baruch S. Blumberg Institute to accelerate the advancement of “bench to bedside” biomedical rese…
Wistar Scientists Discover Innate Tumor Suppression Mechanism
PHILADELPHIA — (MAY 4, 2023) — The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is forming and to kill it. While the gene was discovered more than four …
Second Annual Shark Tank Event is Smooth Sailing for Students
Students participating in the Institute’s Life Science Innovation Course cap their experience with a final business pitch. Over a cup of coffee several years ago, Dr. David Zuzga, Associate Dean of Biomedical Studies, and Heather Steinman, Senior …
Dr. Luis Montaner Visits Vietnam for Official Launch of AMOHI Clinical Trial
Montaner, together with international delegations, attended the April 4 launch in Ho Chi Min City. On April 4, tucked in a courtyard at the Go Vap District Health Center in Vietnam’s Ho Chi Min City, Dr. Luis J. Montaner joined local and internati…
The Wistar Institute Appoints Legal and Life Sciences Expert Squire Servance to Its Board of Trustees
PHILADELPHIA — (MARCH, 30, 2023) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Squire Servance, founder and managing partner for the Princeton, NJ-based life scie…
Researchers Identify a Plant-based Compound that Inhibits Reactivation of the HIV Viral Reservoir, Giving the Immune System a Break
PHILADELPHIA — (MARCH 28, 2023) — As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these individuals to live productive, symptom-free lives, but a cure that perman…
Women in Science Virtual Event Thursday April 27, 2023 at 5 pm
Dr. Maria Elena Bottazzi is the distinguished speaker for The Wistar Institute Women & Science Program on April 27, 2023 at 5:00 – 6:00 p.m. Dr. Bottazzi is Associate Dean of the National School of Tropical Medicine, Professor of Pediatr…
With Philadelphia Foundation Grant, Wistar Advances COVID-19 and Monkeypox Vaccine Response in Vulnerable Populations
An $80,000 grant for The Wistar Institute’s HIV-1 Patient Partnership for Basic Research program from the Robert I. Jacobs Fund of Philadelphia Foundation not only advances ongoing basic research into ways to prevent, treat and ultimately cure HIV…